Pain in the breast

Efficacy of Darchini (Cinnamomum zeylanicum) in Cyclical Mastalgia: A Randomized Controlled Trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/02/030992

Enrollment

Registered

2021-02-04

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N644- Mastodynia

Interventions

Intervention1: Darchini 500mg: 1 capsule Darchini 500mg will be given daily after food from 14 days before the expected date of mense till the commencement of menses for two consecutive cycles Control

Eligibility

Inclusion criteria

Inclusion criteria: Women presenting with cyclical mastalgia defined as occurance of pain within 2 weeks of menstrual onset relieved by menses . Bodymass index between 19 and 29. Regular menstrual cycle between 21 to 35 days.

Exclusion criteria

Exclusion criteria: Lactating and pregnant women. H/O malignancies in first degree relatives. H/O medication for mastalgia. H/O acid peptic disorder. H/O any kind of cyst, tumour and malignancies in the breast. H/O any systemic and metabolic diseases. Patients on regular NSAIDS or anticoagulant therapy. History of danazol, bromocriptine or tamoxifen use in the last 3 months

Design outcomes

Primary

Measure	Time frame
Change in breast pain scoreTimepoint: 2 consecutive cycles	—

Secondary

Measure	Time frame
Change in quality of lifeTimepoint: 2 consecutive cycles	—

Countries

India

Contacts

Public ContactDr Mariyam Roqaiya

Luqman Unani Medical College, Hospital and Research Centre

aqilquadri@yahoo.com9849090182

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026